?:authorAffiliation
|
-
[\'Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany.\', \'Testing Laboratory for In-vitro Diagnostic Medical Devices, Paul-Ehrlich-Institute, Langen, Germany.\', \'Charité - Universitätsmedizin Berlin, Institute of Virology and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany.\', \'Labor Berlin, Charité - Vivantes GmbH, Berlin, Germany.\', \'Bundeswehr Institute of Microbiology and German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany.\', \'LADR Central Laboratory Dr. Kramer & Colleagues, Geesthacht, Germany.\', \'MVZ Labor28 GmbH, Berlin, Germany.\', \'Bernhard Nocht Institute for Tropical Medicine, Arbovirology Department, Hamburg, Germany.\', \'Department of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, Rostock, Germany.\']
|